The use of 3-D cell culture technologies has grown in popularity for cell research, particularly for applications in cancer research and therapy, cell interactions, high-throughput screening and tissue engineering. In contrast to 2-D cell cultures, which are typically performed in petri dishes, 3-D cell cultures generally employ a scaffold or extracellular matrix (ECM), where cells […]
Company Announcements In November 2013, ATAC acquired Research Equipment London, a lab cone and plate viscometer firm. Micromeritics acquired in November 2013 PoroTechnology, a provider of mercury injection capillary pressure rock property data. For the fiscal year ending September 28, 2013, MTS Systems reported that Materials Testing orders within its Test segment were flat. Evergreen […]
Company Announcements Biocartis completed a €30 million ($40 million) Series E equity fundraising in November 2013. BioMérieux and Biocartis agreed in November 2013 to terminate their collaboration. BioMérieux remains a Biocartis shareholder. Agilent Technologies announced in November 2013 a collaboration with Baylor College of Medicine’s Medical Genetics Laboratories to provide customized comparative genomics hybridization (CGH) […]
Company Announcements Agilent Technologies is collaborating with Australia’s University of Queensland Centre for Clinical Research on oral cancer research. The Centre will use Agilent’s SureSelect target enrichment system. In December 2013, Appistry added new Broad Institute tools for next generation sequencing (NGS) analysis to its Cancer Genome Analysis Suite, including the ContEst tool for estimating […]
NanoString Technologies and Luminex also exceeded fourth quarter 2013 adjusted EPS estimates. On February 26, NanoString projected 2014 sales to grow 43%–59% to $45–$50 million with a net operating loss of $40–$50 million. Shares climbed 2.7% the next day. On February 3, Luminex projected 2014 sales to grow 5%–12% to $225–$240 million, in line with […]
Because the European Commission no longer classifies Switzerland as an associated country to Horizon 2020, Swiss science funding applications in 2014 will not receive equal consideration to those of EU states. Switzerland will not qualify for European Research Council funds, and its participation in research consortia will not contribute to meeting Horizon 2020 eligibility criteria. […]
The Chinese National Bureau of Statistics released its Statistical Communiqué of 2013 National Economic and Social Development. R&D spending comprised 2.09% of GDP, rising 15.6% to CNY 1,190.6 billion ($194 billion). CNY 56.9 billion or 4.8% of that amount, was for fundamental research programs. The National Key Technology Research and Development Program and High-tech Research […]
India announced its 2015 interim budget, effective until the full budget is presented after May elections. Budgets of all three Ministry of Science and Technology departments will grow. The Department of Science and Technology will receive INR 3,419.00 crore ($553.4 million), rising 31.2%. Of that, INR 794.00 crore will be for Autonomous Institutions & Professional […]
As required by 2012’s Food and Drug Administration Safety and Innovation Act, the FDA has submitted to Congress a report on premarket notification of changes to 510(k) devices. The agency will largely maintain the present guidance and policy framework and will publish a draft of its revisions for review. The agency will clarify terms in […]
Venture capital investment in the Life Sciences, which includes the Biotechnology and Medical Device industries, decreased in 2013. Biotechnology showed growth, however, with funding increasing 8% to $4,500 million. Numbers of deals, in contrast, decreased by 2% to 470. In the fourth quarter of 2013, Biotechnology investments grew 43% in value to $1,300 million and […]
Pay Invoice
Latest Blogs
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
-
Survey Results: Life Science Labs and Sustainable Consumables
August 30, 2024 7:43 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
